Civica will commercialize the medicine for patients in the United States, after completion of development work and clinical ...

Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), and Civica, Inc. (Civica), a not-for-profit generic drug and ...

The company reported a robust set of numbers for the December quarter of FY25, with its profit nearly doubling year-on-year ...

The Electronics City flyover in Bengaluru will be closed to vehicles from 11 pm to 6 am for maintenance, with traffic ...

Sandoz reported a 9% growth in net sales of generics and biosimilars to third parties for 2024, marking a strong first ...

The company announced that it has secured three orders valued at around ₹500 crore from Power Grid Corporation of India Ltd ...

Dasatinib is prescribed for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia (CML) in adults.

Biocon Ltd is quoting at Rs 320.8, up 1.91% on the day as on 12:49 IST on the NSE. The stock is up 16.87% in last one year as compared to a 0.46% slide in NIFTY and a 4.57% slide in the Nifty Pharma ...

The rise in Biocon share price came after the company announced that its wholly-owned subsidiary, Biocon Pharma, has received ...

Shares of Biocon Ltd rose 3% after Biocon Pharma received FDA approvals for cancer drugs Lenalidomide and Dasatinib, ...